News

Access our monthly newsletter and amplify your learning power by reading the latest from our scientists.

December 2022

Pion Acquires BEE International Adding New Capabilities to an Innovative Portfolio of Formulation Development Technologies for Biopharmaceutical Companies

Pion Acquires BEE International Adding New Capabilities to an Innovative Portfolio of Formulation Development Technologies for Biopharmaceutical Companies

SFW Capital-Backed Pion’s Acquisition of BEE International Adds Next-Generation Emulsifying and Homogenization Technology to Broaden Its Product Portfolio

Pion Inc acquires Two Square Science adding new capabilities to an innovative portfolio for drug development

Pion Inc acquires Two Square Science adding new capabilities to an innovative portfolio for drug development

SFW Capital-Backed Pion’s Acquisition of Two Square Science Adds Sample Preparation and Remote Monitoring Technology to Augment Its Product Portfolio.

October 2022

Pion Inc introduces a new solution for subcutaneous injection formulation development.

Pion Inc introduces a new solution for subcutaneous injection formulation development.

Pion Inc introduces a new solution for subcutaneous injection formulation development.

September 2022

Pion at AAPS PharmSci 360 2022

Pion Showcases How to Achieve In-Vivo Level Insights Via In-Vitro Solutions at AAPS PharmSci 360 2022

Pion showcases how our innovative instruments assist formulation scientists by providing richer, more relevant insights on dissolution, solubility, ionization and much more not easily accessible prior to clinical studies at AAPS PharmSci 360.

June 2022

Pion’s commercial offering goes global with two key appointments

Pion’s commercial offering goes global with two key appointments

Pion, Inc. (“Pion”), a leading provider of analytical instrumentation for formulation development and quality control in the life sciences industry, has announced it is strengthening its commercial team with two key appointments.

March 2022

Jamie Jacques

Pion Boosts Service Offering, Bringing Excellent Customer Experiences to the Forefront

Key Appointments Demonstrate Commitment to Unrivaled Customer Service

November 2021

SCISSOR N3

Pion Inc Unveils New Model of its Industry-First Subcutaneous Injection Site Simulator Investigate Drug Release Performance of Subcutaneous Formulations In Vitro, With New SCISSOR N3

MA. November 16: Pion Inc, leading provider of analytical instruments that bridge the gap between in vitro experiments and in vivo outcomes launches the SCISSOR N3, its new Subcutaneous Injection Site Simulator.

April 2021

March 2021 Newsletter

March 2021 Newsletter

Link to our YouTube Channel for access to all of our webinars and videos

Feb 2021 Newsletter

Feb 2021 Newsletter

Spotlight on Scissor & meet your Account Manager!

January 2021

January 2021 Newsletter: Pion's SiriusT3 & Webinars

January 2021 Newsletter: Pion's SiriusT3 & Webinars

Read about upcoming seminars, FAQ's on the SiriusT3 and more!

December 2020 Newsletter

December 2020 Newsletter

Find link to miniDISS Profiler video and meet new members of the Pion team.

November 2020 Newsletter

November 2020 Newsletter

Read more about the SDi2!

September 2019

Imogen Knight, one of our Analytical Scientists, offers some hints and tips on using the Pion Scissor

Imogen Knight, one of our Analytical Scientists, offers some hints and tips on using the Pion Scissor

Current subcutaneous testing protocols can exhibit extremely poor correlation between animal models and human outcomes and have a high cost and inherent variability associated with in-vivo models.

  • Showing 1 to 13 of 13 entries
  • Previous
  • 1
  • Next

Filter Articles

Close